TXMD (TherapeuticsMD Corp) Projected Price to Earnings

Corporate company logo of TherapeuticsMD (TXMD)

TherapeuticsMD, Inc. (TXMD) price action is subject to the influence of high debt and delisting threats. Changes in the company's expected P/E highlight pressure from generics and the struggle for insurance coverage. A lack of new R&D developments limits growth, and the value of 0.00 shows the current magnitude of this multiple, helping to assess whether a systemic business decline is hidden behind the low price.

Projected Price to Earnings Ratio: therapeuticsmd.com (TXMD) for 07/04/2022 - 11/16/2026

Summary analytical data breakdowns for therapeuticsmd.com (TXMD)

- current price and projected stock value:
Summary company analytics:TherapeuticsMD TXMD
Brand item of TherapeuticsMD, Inc.

Since TherapeuticsMD, Inc. (TXMD) has lost its pricing power by becoming a royalty recipient, the company's forward P/E ratio reflects only market expectations for passive cash flows. This ratio correlates current market capitalization with projected earnings for the following year, allowing investors to assess the premium paid for future income and determine the risk of a correction in the event of inflated market expectations.